CD274 and skin basal cell carcinoma: In addition, Ikeda et al. showed in two cases of BCC the amplification of the 9p24.3–9p22.2 region which contains the PD-L1, PD-L2, and JAK2 genes and typically predict the responsiveness to immunotherapy with anti-PD-1 mAbs in Hodgkin lymphoma [73].